Opening Remarks
Louise Thwaites, Asia Pacific Sepsis Alliance, Vietnam

Opening Remarks
Niranjan 'Tex' Kissoon, Global Sepsis Alliance, Canada

Opening Remarks
Tedros Adhanom Ghebreyesus, Director-General World Health Organization, Switzerland

Opening Remarks
Ricardo Baptista Leite, UNITE Parlamentarians Network for Global Health, Portugal

Reinvigorating Global Action on Sepsis
Konrad Reinhart, Sepsis Stiftung, Germany

2030 Global Agenda for Sepsis | Framework
Mariam Jashi, Global Sepsis Alliance, Germany

Video Messages from Partner Organizations

• David Ripin, Clinton Health Access Initiative (CHAI), United States of America

• Subasree Srinivasan, Global Antibiotic Research & Development Partnership (GARDP), Switzerland

• Eleanor Nwadinobi, Medical Women’s International Association (MWIA), Nigeria

Closing Remarks
Duncan Brown, Australia

Surgical Patients, Multi-Organ Failure, and the SOFA Score
David Harrison, Intensive Care National Audit & Research Centre, United Kingdom

Where Are We with Electronic Sepsis Surveillance and Early Warning Tools?
Frédéric Michard, Michard Consulting, Switzerland

Source Control – When and How?
Jan De Waele, Ghent University Hospital, Belgium

Research Priorities for Sepsis and Septic Shock in Surgical Patients
Lena Napolitano, University of Michigan School of Medicine, United States of America

The Importance of Early Clinical Suspicion in the Diagnosis of Sepsis
Halden Scott, University of Colorado School of Medicine, United States of America

New Data Initiatives for Monitoring Sepsis Globally
Paul Turner, Madihol Oxford Tropical Medicine Research Unit, Cambodia

Data Partnerships: Leveraging Insights from Emerging Infections to Fight Sepsis
Laura Merson, ISARIC, University of Oxford, United Kingdom

Can AI Models Really Improve Sepsis Outcomes?
Paul Elbers, Amsterdam UMC, The Netherlands

Developing Equitable AI for Sepsis Prediction in Children
María del Pilar Arias, Dr. Ricardo Gutiérrez Children’s Hospital, Argentina

From the Research Lab to the Wards: Designing AI Systems for Patient Safety and Clinical Usability
Chris Paton, University of Otago, New Zealand

Desired and Undesired Effects of Fluids
Manu Malbrain, International Fluid Academy, Poland

Diagnosis and Management of Hypervolemia in Sepsis
Sheila Myatra, Asia Pacific Sepsis Alliance, India

Can Early Use of Vasopressors Avoid Hypervolemia?
Jean-Louis Teboul, University Paris-Saclay, France

The Safety Limits to Stop Fluid Infusions
Ludhmila Hajjar, University of São Paulo, Brazil

Fluid Removal: When and How?
Marlies Ostermann, Guy’s and St Thomas’ NHS Foundation Trust, United Kingdom

Biomarkers of Relevance in Low-Resource Settings
Andrew Argent, University of Capetown, South Africa

A Patient is Admitted at the Emergency: What to Do?
Rita Murri, Gemelli University of Rome, Italy

Clinical Phenotypes: What Do They Suggest?
Chris Seymour, University of Pittsburgh, United States of America

Biomarkers as Endpoints for Treatment Efficacy
Evangelos J. Giamarellos-Bourboulis, European Sepsis Alliance, Greece

Reducing Antibiotics With a Single Host Biomarker in Neonates Suspected of LOS: The Emeraude Study
Sylvie Pons, Joint Research Unit Hospices Civils de Lyon – bioMérieux, France

New Global Definition of Acute Respiratory Distress Syndrome (ARDS)
Michael Matthay, University of California San Francisco, United States of America

Alveolar Inflammation in ARDS
Lieuwe Bos, Amsterdam UMC, The Netherlands

Biomarkers in ARDS and Sepsis
Lorraine Ware, Vanderbilt University, United States of America

Unraveling the Enigma of Genetics and Phenotypes in Sepsis and ARDS
Carmen Barbas, University of São Paulo, Brazil

Diagnosis of Ventilator-Associated Pneumonia
Pedro Povoa, University of Lisboa, Portugal

Ventilator Support and Sepsis in Low-Middle Income Countries
Marcus Schultz, Mahidol University, Thailand

The Phoenix Criteria – How We Got Here
Luregn Schlapbach, University Children’s Hospital Zurich, Switzerland

The Phoenix Criteria Revealed
Daniela de Souza, Global Sepsis Alliance, Brazil

Personalized Care Post-Discharge for Sepsis
Matthew Wiens, University of British Columbia, Canada

The Latest Update on Fluid Therapy in Sepsis
Jhuma Sankar, All India Institute of Medical Sciences, India

The Advances of the WHO in Pediatric Sepsis Initiatives
Emilie Calvello-Hynes, World Health Organization, Switzerland

Empiric Treatment of Neonatal Sepsis: Progress to Date
Sally Ellis, Global Antibiotic Research & Development Partnership, Switzerland

TREM-1 Pathway
Bruno Francois, Dupuytren University Hospital, France

ARDS: Room for Precision Treatment?
Carolyn Calfee, University of California, San Francisco Medical Center, United States of America

Modulation of Complement
Alexander Vlaar, Amsterdam UMC, The Netherlands

Macrolides for Community-Acquired Pneumonia
Michael Niederman, Weill Cornell Medicine, United States of America

Reversal of Immunoparalysis
Sara Cajander, Örebro University, Hospital, Sweden

ARCS: Understanding Risk Factors for Delayed Presentation and Care of Sepsis Patients in DRC, Nigeria, and Sierra Leone
Patrick de Marie Katoto, Catholic University of Bukavu, DRC

Sepsis Check – A Preclinical Checklist for Early Detection and Education
Wiltrud Abels, Charité – Universitätsmedizin Berlin, Germany

Early Resuscitation of Septic Shock in the ED – Which Perfusion Parameters for Target Resuscitation?
Glenn Hernández Poblete, Pontifical Catholic University of Chile, Chile

Sepsis in Brazilian Emergency Departments: A Prospective Multicenter Observational Study
Flavia Machado, Latin American Sepsis Institute, Brazil

Smart Triage: Electronic Support for Early Recognition and Triage of Severely Ill Patients in Ugandan Emergency Departments
Mark Ansermino, BC Children’s Hospital, Canada

Closing Remarks
Michael Wong, Physician-Patient Alliance for Health & Safety, United States of America